Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Akari Therapeutics Plc Appoints Abizer Gaslightwala As President and CEO

PUBLIC · AKTXMar 20, 2025•about 1 year ago

Position

Chief Executive Officer

Company

Akari Therapeutics

Abizer Gaslightwala

TampaBiotechnologyresearch

Description

Akari Therapeutics Plc announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer (CEO), effective April 21, 2025. He brings 25 years of experience in the biotechnology and pharmaceutical industry, having most recently served as the Senior Vice President and Franchise Head for US Oncology at Jazz Pharmaceuticals.

Company Information

Company

Akari Therapeutics

Location

401 EAST JACKSON STREET

Tampa, Florida, United States

About

Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells. Unlike traditional ADC payloads, PH1 induces cancer cell death while activating immune responses, showing robust and durable activity in preclinical models.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Akari Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months